DNA methylation variability provides a complementary epigenetic signature of aging heterogeneity: findings from the Canadian Longitudinal Study on Aging and the Baltimore Longitudinal Study of Aging
The Journals of Gerontology, Series A: Biological Sciences and Medical Sciences · 06.10.2026 · 81 (11)
DOI: 10.1093/gerona/glag234 ↗Kurz gefasst
Fachartikel in der Zeitschrift The Journals of Gerontology, Series A: Biological Sciences and Medical Sciences, online erschienen am 17.09.2026. Verfasst von Olga Vishnyakova und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Basic and Translational Research, BC Cancer, Vancouver, British Columbia, Canada. Hauptthemen laut MEDLINE: DNA Methylation, Aging, Epigenesis, Genetic. Die Arbeit nennt 46 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: CIHR, Canadian Institutes of Health Research.
Abstract (Originalsprache)
Background
Human aging does not follow a single trajectory. Epigenetic changes offer insight into the heterogeneity in aging by reflecting the combined influence of genetic, environmental, and lifestyle factors on the timing and progression of age-related changes beyond what chronological age alone can explain. Recent studies in cancer and aging underscore the importance of methylation variability as a marker of biological dysregulation.
Methods
We investigated the role of DNA methylation in aging heterogeneity by performing epigenome-wide differential methylation and variance association analyses in blood samples from 1445 Canadians aged 45 to 85 from the Canadian Longitudinal Study on Aging.
Results
We identified 448 differentially methylated regions and 488 differentially variable regions associated with health decline as measured by the health deficit accumulation frailty index, cognitive function, and physical function. These two classes of regions showed minimal overlap, with distinct gene coverage, suggesting that variability contributes a complementary signal to aging heterogeneity. Genes overlapped by differentially methylated regions were enriched for immune and inflammation-related pathways, whereas differentially variable regions highlighted additional localized, CpG‑island-enriched signals shared across health domains, consistent with regionally structured rather than diffuse dysregulation. By integrating significant CpGs from both analyses, we constructed an epigenetic biomarker. The biomarker was associated with all-cause mortality and showed higher discrimination than biomarkers constructed from differential methylation or variability alone, with a similar pattern reproduced in the Baltimore Longitudinal Study of Aging.
Conclusions
These findings suggest that DNA methylation variability may provide a complementary dimension of epigenetic aging and support further evaluation in larger cohorts with more mortality events.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Basic and Translational Research, BC Cancer, Vancouver, British Columbia, Canada.
- Department of Biomedical Physiology and Kinesiology, Simon Fraser University, Burnaby, British Columbia, Canada.
- Department of Statistics and Actuarial Science, Simon Fraser University, Burnaby, British Columbia, Canada.
- Longitudinal Studies Section, Translational Gerontology Branch, National Institute on Aging, Baltimore, Maryland, United States.
- Clinical Research, Surrey Memorial Hospital, Fraser Health, Surrey, British Columbia, Canada.
- Division of Geriatric Medicine, Dalhousie University, Halifax, Nova Scotia, Canada.
ORCID-Profile: Olga Vishnyakova, Toshiko Tanaka, Luigi Ferrucci, Xiaowei Song, Kenneth Rockwood, Angela Brooks-Wilson, Lloyd T Elliott
Förderung
- CIHR
- Canadian Institutes of Health Research
Zitieren
APA
Vishnyakova, O., Min, J., Moore, A. Z., Tanaka, T., Ferrucci, L., Song, X., Rockwood, K., Brooks-Wilson, A., & Elliott, L. T. (2026). DNA methylation variability provides a complementary epigenetic signature of aging heterogeneity: findings from the Canadian Longitudinal Study on Aging and the Baltimore Longitudinal Study of Aging. The Journals of Gerontology, Series A: Biological Sciences and Medical Sciences, 81(11). https://doi.org/10.1093/gerona/glag234
Vancouver
Vishnyakova O, Min J, Moore AZ, Tanaka T, Ferrucci L, Song X, et al. DNA methylation variability provides a complementary epigenetic signature of aging heterogeneity: findings from the Canadian Longitudinal Study on Aging and the Baltimore Longitudinal Study of Aging. The Journals of Gerontology, Series A: Biological Sciences and Medical Sciences. 2026;81(11). doi:10.1093/gerona/glag234
BibTeX
@article{Vishnyakova2026,
author = {Vishnyakova, Olga and Min, Joosung and Moore, Ann Z and Tanaka, Toshiko and Ferrucci, Luigi and Song, Xiaowei and Rockwood, Kenneth and Brooks-Wilson, Angela and Elliott, Lloyd T},
title = {DNA methylation variability provides a complementary epigenetic signature of aging heterogeneity: findings from the Canadian Longitudinal Study on Aging and the Baltimore Longitudinal Study of Aging},
journal = {The Journals of Gerontology, Series A: Biological Sciences and Medical Sciences},
year = {2026},
volume = {81},
number = {11},
doi = {10.1093/gerona/glag234}
}
EUVIMED